The intricate landscape of pharmaceutical synthesis relies on a robust supply of specialized chemical intermediates. Among these, compounds with precise stereochemistry and high purity are indispensable for developing advanced therapeutics. Tert-Butyl (1R,2S,5S)-2-Amino-5-(Dimethylcarbamoyl)Cyclohexylcarbamate Oxalate Hydrate, identified by its unique CAS number 1353893-22-7, is a prime example of such a critical molecule.

NINGBO INNO PHARMCHEM CO., LTD. is at the forefront of providing this essential compound, recognizing its pivotal role in the pharmaceutical industry. Primarily known for its application as an intermediate in the synthesis of Edoxaban, a widely used anticoagulant, this chemical compound’s reliable availability is key for drug manufacturers. The specific (1R,2S,5S) stereochemistry is vital for the biological activity of the final drug product, making precision in its synthesis paramount.

Our company's expertise in pharmaceutical intermediate synthesis ensures that CAS 1353893-22-7 is produced to the highest standards. This meticulous approach allows researchers and manufacturers to confidently integrate it into their complex multi-step syntheses. Beyond its direct use in Edoxaban production, the compound also serves as a valuable building block for a range of other medicinal chemistry applications, offering flexibility for novel drug design and development.

For organizations with unique research needs, NINGBO INNO PHARMCHEM CO., LTD. offers comprehensive custom synthesis pharmaceutical services. This means we can tailor the production of intermediates like CAS 1353893-22-7 to specific purity requirements, quantities, or even modified structures, thereby supporting bespoke drug discovery projects. By partnering with us, you gain access to not only high-quality chemicals but also the expertise needed to overcome synthetic challenges and accelerate your R&D timelines.